|Day's Range||140.41 - 140.91|
|52 Week Range||119.51 - 146.63|
|PE Ratio (TTM)||19.30|
|Earnings Date||Jul 25, 2017 - Jul 31, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||155.89|
Leading diagnostics testing company LabCorp (LH) recently announced the availability of Sera Prognostics, Inc.'s PreTRM test at its laboratories in the U.S.
LabCorp® today announced the nationwide availability of the PreTRM® test. Developed by Sera Prognostics, Inc., the PreTRM test is the first of its kind validated blood test that provides an early and individualized prediction of preterm birth risk for pregnant women.
LabCorp® today announced it will participate at the Bank of America Merrill Lynch 2017 Health Care Conference. LabCorp’s presentation is scheduled for Tuesday, May 16, 2017, at 10:40 a.m.